about
The paradox role of caspase cascade in ionizing radiation therapyOral oxymetholone reduces mortality induced by gamma irradiation in mice through stimulation of hematopoietic cells.Trends in the development of radioprotective agents.Flavonoids and genomic instability induced by ionizing radiation.Antiangiogenic agents in natural products for the treatment of gynecologic disorders.Beneficial effects of natural products on cells during ionizing radiation.Role of CHK2 inhibitors in the cellular responses to ionizing radiation.The use of angiotensin II receptor antagonists to increase the efficacy of radiotherapy in cancer treatment.Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers.The protective effects of trace elements against side effects induced by ionizing radiationNatural Products for Management of Oral Mucositis Induced by Radiotherapy and Chemotherapy.Comparative assessment of a 99mTc labeled H1299.2-HYNIC peptide bearing two different co-ligands for tumor-targeted imaging.Preparation and biological evaluation of 99mTc-HYNIC-(Ser)3-D4 peptide for targeting and imaging of non-small-cell lung cancer.New small 99mTc-labeled peptides for HER2 receptor imaging.99m Tc-anti-epidermal growth factor receptor nanobody for tumor imaging.The Role of NF-kB Inhibitors in Cell Response to Radiation.The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers.Nuclear medicine for imaging of epithelial ovarian cancer.Losartan sensitizes selectively prostate cancer cell to ionizing radiation.The Past, Current Studies and Future of Organometallic 99mTc(CO)3 Labeled Peptides and Proteins.Radiosensitization Effects of a Zataria multiflora Extract on Human Glioblastoma Cells.The Influence of Co-Ligands on Improving Tumor Targeting of <sup>99m</sup>Tc-HYNIC Conjugated Peptides.Celecoxib mitigates genotoxicity induced by ionizing radiation in human blood lymphocytes.Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591.HAHAHA, HEHEHE, HIHIHI, or HKHKHK: influence of position and composition of histidine containing tags on biodistribution of [(99m)Tc(CO)3](+)-labeled affibody molecules.The radioprotective effect of metformin against cytotoxicity and genotoxicity induced by ionizing radiation in cultured human blood lymphocytes.HEHEHE-tagged affibody molecule may be purified by IMAC, is conveniently labeled with [⁹⁹(m)Tc(CO)₃](+), and shows improved biodistribution with reduced hepatic radioactivity accumulation.Radioprotective Effect of Achillea millefolium L Against Genotoxicity Induced by Ionizing Radiation in Human Normal Lymphocytes.Protective effects of curcumin against genotoxicity induced by 131-iodine in human cultured lymphocyte cells.Radiosensitive effect of curcumin on thyroid cancer cell death induced by radioiodine-131.Radioprotective effect of chicory seeds against genotoxicity induced by ionizing radiation in human normal lymphocytes.The effects of Arnebia euchroma ointment on second-degree burn wounds: a randomized clinical trial.In vitro protective effect of atorvastatin against ionizing radiation induced genotoxicity in human lymphocytes.Determination of the severity of ureteropelvic junction obstruction using urinary epidermal growth factor and kidney injury molecule 1 levels.The Healing Effect of Arnebia Euchroma Ointment versus Silver Sulfadiazine on Burn Wounds in Rat.The Effects of Punica granatum Flower Extract on Skin Injuries Induced by Burn in Rats.Genotoxicity induced by iodine-131 in human cultured lymphocytes.Protective effect of hawthorn extract against genotoxicity induced by cyclophosphamide in mouse bone marrow cells.Resveratrol sensitizes selectively thyroid cancer cell to 131-iodine toxicity.
P50
Q28079723-42F2664C-4493-4BFE-8D4C-33ECE5BFCA84Q33370530-9C1E7299-5103-4C05-8BD8-AE94FA900D0FQ36969642-B6EB56D5-4942-4F3E-AE8B-5BE7ED278696Q37798932-0C89D434-B2B4-4AA5-832E-FCF5F513DFA1Q38177316-F0A6CDCE-1989-426D-AC17-387A0B69A239Q38201601-479526E9-3327-4164-B12B-95A63DE8ED02Q38259326-31A7C80D-4142-4278-9C36-76A94FC6DFBCQ38294600-589B0B49-BC6D-4963-B9DD-397B6B777918Q38301100-4490F386-2D4B-4933-9707-3E7CA2454F20Q38312110-DD10C6E0-9E10-480F-A4AD-46222283F946Q38544302-1203A1B0-20D1-4C31-8AD8-576C72ED7C6EQ38573679-788C82A3-B781-47B0-BF95-60F8C2F745E0Q38709841-043C805A-F507-49FD-9CC1-259EC72AC760Q38720107-B6A6620D-AF53-4508-B5E6-E50A6655EEF6Q38731118-F31BA419-74BB-497C-A5E9-B5430729E721Q38744686-EAFA2912-9841-4F20-B1AD-06DA0687386BQ38750492-CC83AA95-8C0A-46AD-B750-F9465C0C5350Q38765839-F90B3241-A651-4BF4-96AB-672571DCF928Q38777588-EF211DE9-7DB4-4234-980A-F44ED8B54579Q38797828-F813C2A1-53C6-4F3C-8128-DAC66C0B2321Q38804037-42E49D2B-7430-47F1-9532-90D84628E93CQ38823878-CF4C60F3-554E-45AA-80A4-C244CF2FCFACQ38925348-6748A2BC-1561-44B6-A6FC-EB76C70DB3CCQ38932111-DB546CFB-2B24-4CAC-8448-A4EA3E5F818CQ39035754-B88CB574-C4BB-4BCE-AB2A-D8344D73923DQ39149185-1840D380-4F69-44DF-BC50-214FE5840B51Q39333150-5E7C602C-73DA-4162-BAEB-704B83DD8030Q39641521-09E00C08-5CBC-4CAA-B3C2-4E2FECE03A70Q40204205-8BC542FB-01DD-4C2A-8553-677421FDBF47Q40409652-31AA10B6-2CAD-4B77-AAC4-18CE8458B47CQ40546814-C7E1D9CF-B2E0-4AD4-8349-8A3E08FF5B31Q40638302-8518B4AD-620C-4D6F-98A7-D935846C1EDAQ40674146-2BD41133-3A19-4EB2-A4D1-9A76230E0183Q41148075-4B4593FC-9145-4D51-A2DE-95671EF6DF62Q41590362-85C1DD9C-229E-447D-AC0B-62C590AEE59AQ41847053-7C9CF88B-C2D0-45AB-9011-753D6710FC88Q42324580-0DCA02EA-D3B9-4CA3-8CB8-7948CB653148Q42683054-C566BBD9-9AF2-48E0-82F1-FF6C1F72406DQ42729504-887EBE67-9030-403F-98C8-0A948CBFD035Q42909056-568268D7-486A-4AC3-9413-65D1A0978604
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Seyed Jalal Hosseinimehr
@ast
Seyed Jalal Hosseinimehr
@en
Seyed Jalal Hosseinimehr
@es
Seyed Jalal Hosseinimehr
@nl
Seyed Jalal Hosseinimehr
@sl
type
label
Seyed Jalal Hosseinimehr
@ast
Seyed Jalal Hosseinimehr
@en
Seyed Jalal Hosseinimehr
@es
Seyed Jalal Hosseinimehr
@nl
Seyed Jalal Hosseinimehr
@sl
prefLabel
Seyed Jalal Hosseinimehr
@ast
Seyed Jalal Hosseinimehr
@en
Seyed Jalal Hosseinimehr
@es
Seyed Jalal Hosseinimehr
@nl
Seyed Jalal Hosseinimehr
@sl
P214
P106
P1153
6505898135
P214
P31
P496
0000-0001-8055-8036
P7859
viaf-311813231